glp 1 agonist drug Glucagon-like peptide-1 Lower doses of the GLP-1

10.2147/JHC.S433332 278 XuJ.WangY.WangA.GaoZ.GaoX.ChenH.et al (2019)

GLP-1s expose this gap

The cleaved N-terminal fragment of GSDME forms pores in the cell membrane, triggering pyroptosis, which is characterized by cell swelling, rupture, and the release of pro-inflammatory signals

This improvement is realized by enhancing insulin secretion through a non-oxidative stress pathway involving the activation of MAPK/PI3K to phosphorylate Nrf2, facilitating its nuclear translocation, binding to the ARE promoter, and ultimately boosting antioxidant gene expression (Thomas et al., 2017)

Combining GHK-Cu with Other Treatments GHK-Cu can be incorporated into broader skin rejuvenation protocols alongside other peptides, treatments, and lifestyle approaches